Literature DB >> 10755286

Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age.

R S Wilson1, D W Gilley, D A Bennett, L A Beckett, D A Evans.   

Abstract

Change in global and specific measures of cognitive function was studied in a cohort of 410 persons with Alzheimer's disease. Persons completed up to 5 annual evaluations; follow-up participation among survivors exceeded 90%. Average annual decline was 0.57 standard score units (95% confidence interval [CI]: -0.51 to -0.62) on a composite measure based on 17 individual tests and 3.26 points (95% CI: -3.06 to 3.46) on the Mini-Mental State Examination, but substantial heterogeneity was apparent. On both global and specific measures, rate of cognitive decline was reduced in older persons compared with younger persons. A similar effect was observed for estimated age of disease onset. The effect of age was approximately linear and was not attributable to education, sex, race, other conditions that impair cognition, or mortality. The results indicate that person-specific paths of cognitive decline in Alzheimer's disease vary substantially and suggest that in clinical settings some of this variability is related to age.

Entities:  

Mesh:

Year:  2000        PMID: 10755286     DOI: 10.1037//0882-7974.15.1.18

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  28 in total

1.  Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Christopher D Corcoran; Maria C Norton; Peter V Rabins; Martin I Steinberg; Joann T Tschanz; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

2.  Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans.

Authors:  Ainie Soetanto; Robert S Wilson; Konrad Talbot; Ashley Un; Julie A Schneider; Mark Sobiesk; Jeremiah Kelly; Sue Leurgans; David A Bennett; Steven E Arnold
Journal:  Arch Gen Psychiatry       Date:  2010-05

3.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

4.  Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.

Authors:  JoAnn T Tschanz; Chris D Corcoran; Sarah Schwartz; Katherine Treiber; Robert C Green; Maria C Norton; Michelle M Mielke; Kathleen Piercy; Martin Steinberg; Peter V Rabins; Jeanne-Marie Leoutsakos; Kathleen A Welsh-Bohmer; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2011-06       Impact factor: 4.105

5.  Heterogeneity of cognitive trajectories in diverse older persons.

Authors:  Dan Mungas; Laurel Beckett; Danielle Harvey; Sarah Tomaszewski Farias; Bruce Reed; Owen Carmichael; John Olichney; Joshua Miller; Charles DeCarli
Journal:  Psychol Aging       Date:  2010-09

Review 6.  Structural imaging measures of brain aging.

Authors:  Samuel N Lockhart; Charles DeCarli
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

7.  A genome-wide scan for common variants affecting the rate of age-related cognitive decline.

Authors:  Philip L De Jager; Joshua M Shulman; Lori B Chibnik; Brendan T Keenan; Towfique Raj; Robert S Wilson; Lei Yu; Sue E Leurgans; Dong Tran; Cristin Aubin; Christopher D Anderson; Alessandro Biffi; Jason J Corneveaux; Matthew J Huentelman; Jonathan Rosand; Mark J Daly; Amanda J Myers; Eric M Reiman; David A Bennett; Denis A Evans
Journal:  Neurobiol Aging       Date:  2011-11-04       Impact factor: 4.673

8.  Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?

Authors:  Jennifer G Goldman; Samantha Holden; Bichun Ouyang; Bryan Bernard; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

9.  Medical decision-making capacity in mild cognitive impairment: a 3-year longitudinal study.

Authors:  O C Okonkwo; H R Griffith; J N Copeland; K Belue; S Lanza; E Y Zamrini; L E Harrell; J C Brockington; D Clark; R Raman; D C Marson
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

10.  Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores.

Authors:  Jeremiah F Kelly; Julia L Bienias; Avni Shah; Kathleen A Meeke; Julie A Schneider; Edwin Soriano; David A Bennett
Journal:  Curr Alzheimer Res       Date:  2008-02       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.